PEOPLE - TM Bioscience makes appointment:
This article was originally published in Clinica
TM Bioscience (Toronto, Ontario), a DNA-based diagnostics firm, has appointed Paul Lucas as chairman of its board of directors, effective immediately. Mr Lucas is currently president of and CEO of GSK Canada, and has been an independent director of TM Bioscience since 2002. In addition, Dr Neil Reid has been named vice-chairman and Michael Mueller has been appointed a director.